WHOOP, Field Trip partner to study impact of psychedelic therapies
Category: #health  By Nikita Chaurasia  Date: 2020-11-21
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

WHOOP, Field Trip partner to study impact of psychedelic therapies

WHOOP Inc., a prominent provider of health tracking and monitoring services, has reportedly announced a partnership with Field Trip Health Ltd., leader in development and delivery of psychedelic therapies. According to reliable sources, Field Trip will use WHOOP’s Strap 3.0 in order to determine biometric effects of its psychedelic therapies on mental and physiology health.

Field Trip reportedly intends to perform an observational study to understand if its ketamine-assisted therapies, which have been proved to be beneficial in treating mental health conditions including PTSD, anxiety, and depression, could improve physical health as well.

It is to be noted that, Field Trip has acquired WHOOP products and has gained access to additional data insights through a research collaboration and enterprise program. The firm is also planning to open Field Trip Health centers across Europe and North America for delivering their psychedelic therapies.

Dr. Ryan Yermus, Chief Clinical Officer at Field Trip, mentioned in a comment that clinical outcomes from their first three centers in Los Angeles, New York, and Toronto, have been overwhelmingly positive, with a substantial decrease in depressive symptoms, trauma-related symptoms, and anxiety.

If reports are to be believed, the research will initially be conducted on military veterans seeking ketamine-assisted therapies via Basecamp program of Field Trip and then expand to the generic public.

Some studies have already proved that physiological metrics such as slow wave sleep patterns and HRV will be improved via psychedelic therapies of Field Trip, sources confirmed. The potential collaboration between the two companies is to better understand the connection between physiology and mental wellbeing.

As per credible sources, WHOOP was recently valued at USD 1.2 billion after receiving over USD 100 million in a Series E funding round. At present, the company's bands are being used in a COVID-19 vaccine trials and have also been used on the LPGA tour to track the health of sports players.

Source Credits- https://www.globenewswire.com/news-release/2020/11/19/2130016/0/en/Field-Trip-Health-Ltd-and-WHOOP-announce-partnership-to-measure-effect-of-psychedelic-therapies-on-physiology-and-mental-health.html

 

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Ford takes on GM, Tesla by debuting its first hands-free driving system

Ford takes on GM, Tesla by debuting its first hands-free driving system

By Nikita Chaurasia

Ford Motor Company, the American multinational automaker, is reportedly planning on introducing a hands-free driving feature on its 2021 Mustang Models as well as 2021 F-150 pickup truck through a software update, by the end of the year. The automob...

Oculus Quest 2 update to include wireless PC streaming, 120Hz mode

Oculus Quest 2 update to include wireless PC streaming, 120Hz mode

By Nikita Chaurasia

Oculus, a subsidiary of Facebook, Inc., that develops and manufactures virtual reality headsets, has recently announced that Oculus Quest 2’s new v28 software update will include native wireless desktop PC streaming as well as 120 Hz refresh ra...

Levi’s boosts its sales outlook for first half of 2021 on vaccine hopes

Levi’s boosts its sales outlook for first half of 2021 on vaccine hopes

By Nikita Chaurasia

Levi Strauss & Co., an American clothing company, has reportedly raised its half-yearly revenue growth projection, counting on COVID-19 vaccine rollouts to reinstate the popularity of its physical stores. The denim-maker had previously beaten est...